Menopause hormone therapy: latest developments and clinical practice
Drugs in Context, 2019 Menopause hormone therapy (MHT) is the most efficient treatment for symptoms of acute climacteric syndrome and for efficient prevention of long-term estrogen deficiency. Vaginal administration of low doses of estrogen is a therapy of choice for treatment
Tomas Fait
doaj +1 more source
Health considerations for transgender women and remaining unknowns : a narrative review [PDF]
, 2019 Transgender (trans) women (TW) were assigned male at birth but have a female gender identity or gender expression. The literature on management and health outcomes of TW has grown recently with more publication of research.
Defreyne, Justine +6 more
core +1 more source
Which patients with prostate cancer are actually candidates for hormone therapy?
International Brazilian Journal of Urology, 2004 In this article, we will try to address the following aspects: which factors are responsible of the introduction of new candidates for hormone therapy in prostate cancer, who are actually candidates for hormone therapy, classifying them on the basis of ...
Alessandro Sciarra +5 more
doaj +1 more source
Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women [PDF]
, 2001 The mechanisms that mediate the cardioprotective action of steroid hormones in postmenopausal women are poorly understood. To study the inter-relationship between female steroid hormones and cardiac natriuretic peptides, plasma levels of atrial ...
A. Clerico +3 more
core +1 more source
The role of stereotactic radiosurgery in the multimodal management of growth hormone–secreting pituitary adenomas [PDF]
, 2010 Growth hormone (GH)–secreting pituitary adenomas represent a common source of GH excess in patients with acromegaly. Whereas surgical extirpation of the culprit lesion is considered first-line treatment, as many as 19% of patients develop recurrent ...
Liu, Charles Y. +2 more
core +1 more source
PLoS Medicine, 2011 BackgroundEven after the Women's Health Initiative (WHI) found that the risks of menopausal hormone therapy (hormone therapy) outweighed benefit for asymptomatic women, about half of gynecologists in the United States continued to believe that hormones ...
Adriane Fugh-Berman +4 more
doaj +1 more source
Effects of human recombinant growth hormone on exercise capacity, cardiac structure, and cardiac function in patients with adult-onset growth hormone deficiency [PDF]
, 2017 Objective Epidemiological studies suggest that adult-onset growth hormone deficiency (AGHD) might increase the risk of death from cardiovascular causes. Methods This was a 6-month double-blind, placebo-controlled, randomised, cross-over trial followed by
Atkin, S. L. +11 more
core +1 more source
Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial
BMC Women's Health, 2008 Background The aim of the study was to determine the effect of postmenopausal hormone therapy on women's symptom reporting and quality of life in a randomized trial.
Rahu Mati +5 more
doaj +1 more source
Advanced Medical Journal, 2023 Background and objectives: To find out the response to growth hormone therapy among growth hormone deficiency patients with different causes and to find out the role of insulin-like growth factor one in monitoring response.
Kawes Omer Zangana +2 more
doaj +1 more source
Correction of menopausal disorders: new possibilities of menopausal hormone therapy
Медицинский совет, 2022 Determining the role of menopausal hormone therapy in the era of covid infection is an urgent task. The reasons for the lower rate of severe outcomes in women against the background of covid infection compared to men are currently being discussed.
L. Yu. Karakhalis
doaj +1 more source